2-MIN READ

'Bold and Beautiful': USAIC Hails PM Modi's Multi-Pronged Strategy to Contain Coronavirus

For representation: A woman walks along a near-empty street during a lockdown amid a coronavirus disease (COVID-19) outbreak. (REUTERS/Image for representation)

For representation: A woman walks along a near-empty street during a lockdown amid a coronavirus disease (COVID-19) outbreak. (REUTERS/Image for representation)

USA India Chamber of Commerce said the Indian government's decision of announcing financial packages as the virus damaged economy showed the 'political will' to doge the full hit of the pandemic.

  • PTI
  • Last Updated: March 27, 2020, 9:17 AM IST
Share this:

Washington: Terming India's 21-day nationwide lockdown as a "bold and difficult" decision, a top Indian-American pharma industry expert on Thursday said the country is using a multi-pronged strategy to contain the deadly coronavirus.

To lockdown India for 21 days to contain COVID-19 was a bold and difficult decision based on scientific reasoning. No other country in the world has taken such a courageous decision to implement social distancing, Karun Rishi, president of USA India Chamber of Commerce (USAIC) said.

So far, it has appeared to dodge the full hit of the pandemic, said Rishi.

Based out of Boston, which is the hub of health and pharma sector in the US, USAIC every year organizes a US-Indian pharma summit attended by top industry and government leaders and officials from the two countries.

Prime Minister Narendra Modi has used multi-pronged strategy to contain and manage the COVID-19 virus in India, he said.

The first step is taken, he said, was a policy initiative last week to boost manufacturing of bulk drugs and active pharmaceutical ingredients (APIs).

The substantial financial package announced by India in these difficult economic times to encourage domestic manufacture of Key Starting Materials (KSM), drug intermediates, and active pharmaceutical ingredients (APIs) show the political will and resolve of the leadership to make India self-reliant for the domestic and export markets, he said.

Only economies of scale in manufacturing can ensure affordable drug prices for patients. This policy envisions a set of schemes to reap economies of scale and ready availability of inputs in the production of APIs via the cluster approach. This will help India achieve drug security through self-sufficiency in manufacturing of at least 53 critical bulk drugs, he added.

Asserting that social distancing is the only way to combat the spread of coronavirus, he noted that India with 1.3 billion people is the world's second-most populous country and the fifth-biggest economy. And so far, it has appeared to dodge the full hit of the pandemic, he observed.

There are less than 10,000 ICU and fewer than 40,000 isolation beds in India. A vast majority of these are already occupied by existing patients, he said.

If India follows Italy's trajectory, for example, it would be a catastrophe, especially in the poorer Indian states, which have next to zero capacity to cope with this pandemic.

"Priority of the government was saving lives of people. India has shown effective leadership by announcing a nationwide lockdown to tackle coronavirus. This will save millions of lives, Rishi said.

Share this:
Next Story

India

  • Active Cases

    3,666

     
  • Total Confirmed

    4,067

     
  • Cured/Discharged

    291

     
  • Total DEATHS

    109

     
Data Source: Ministry of Health and Family Welfare, India
Updated: April 06 (09:00 AM)
Hospitals & Testing centres

World

  • Active Cases

    941,228

     
  • Total Confirmed

    1,277,259

     
  • Cured/Discharged

    266,461

     
  • Total DEATHS

    69,570

     
Data Source: Johns Hopkins University, U.S. (www.jhu.edu)
Hospitals & Testing centres